Finance

Lists
OCUL:NASDAQ
Ocular Therapeutix Inc
7,74 USD
-1,72%
(-0,13) 1D
30-сен., 15:38:52 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCUL...
Open
7,88 USD
High
8,16 USD
Low
7,63 USD
Mkt. cap
1,70 млд
Avg. vol.
2,87 млн
Volume
3,17 млн
52-wk high
16,44 USD
52-wk low
6,23 USD
EPS
-1,41 USD
Beta
0,97
Shares outstanding
219,62 млн
No. of employees
325
Open
7,88 USD
High
8,16 USD
Low
7,63 USD
Mkt. cap
1,70 млд
Avg. vol.
2,87 млн
Volume
3,17 млн
52-wk high
16,44 USD
52-wk low
6,23 USD
EPS
-1,41 USD
Beta
0,97
Shares outstanding
219,62 млн
No. of employees
325
News stories
From web sources and news partners
About Ocular Therapeutix Inc
CEOPravin Dugel
Employees325
Founded2006
HeadquartersБедфорд, Массачусетс, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websiteocutx.com
Analyst ratings
Based on 8 analysts giving stock ratings to OCUL in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for OCUL in the last 3 months.
Highest
Current 7,74 USD
31,00 USD (+300,78%)
Average
25,57 USD (+230,58%)
Lowest
18,00 USD (+132,71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Biren Amin
Piper Sandler
Buy
Maintained
31,00 USD
+300,8%
09/29/2026
Serge Belanger
Needham
Buy
Maintained
18,00 USD
+132,7%
09/28/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
09/25/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
25,00 USD
+223,2%
09/16/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
27,00 USD
+249,1%
09/15/2026
William Maughan
Clear Street
Buy
Reiterated
28,00 USD
+262%
08/18/2026
Tara Bancroft
TD Cowen
Buy
Maintained
20,00 USD
+158,6%
08/03/2026
Lisa Walter
RBC Capital
Buy
Maintained
30,00 USD
+287,8%
08/03/2026
Daniil Gataulin
Chardan Capital
Buy
Maintained
23,00 USD
+197,3%
06/25/2026
Colleen M. Kusy
Robert W. Baird
Buy
Maintained
30,00 USD
+287,8%
06/18/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
-
-
02/17/2026
Clara Dong
Jefferies
Buy
Maintained
28,00 USD
+262%
02/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
14,54 млн
13,25 млн
10,78 млн
13,48 млн
Cost of goods sold
54,13 млн
52,39 млн
67,54 млн
56,15 млн
Cost of revenue
54,13 млн
52,39 млн
67,54 млн
56,15 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29,11 млн
30,62 млн
36,58 млн
39,44 млн
Operating expense
29,11 млн
30,62 млн
36,58 млн
39,44 млн
Total operating expenses
83,24 млн
83,01 млн
104,12 млн
95,58 млн
Operating income
-68,70 млн
-69,76 млн
-93,34 млн
-82,11 млн
Other non operating income
-1,45 млн
624,00 миң
1,46 млн
689,00 миң
EBT including unusual items
-69,42 млн
-64,65 млн
-88,61 млн
-78,76 млн
EBT excluding unusual items
-69,42 млн
-64,62 млн
-88,61 млн
-78,76 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-69,42 млн
-64,65 млн
-88,61 млн
-78,76 млн
Net profit margin
-477,30%
-487,95%
-821,62%
-584,51%
Earnings per share
-0,38
-0,29
-0,40
-0,35
Interest and investment income
3,73 млн
7,34 млн
6,05 млн
5,45 млн
Interest expense
-3,00 млн
-2,83 млн
-2,78 млн
-2,79 млн
Net interest expenses
727,00 миң
4,51 млн
3,27 млн
2,66 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-67,63 млн
-68,51 млн
-92,06 млн
-80,26 млн
Gain or loss from assets sale
-
-
4,87 млн
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору